Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced enrollment of the first subject in a repeat dose ...

All planned clinical studies in fasedienol U.S. registration-directed Phase 3 program for the acute treatment of social anxiety disorder are underway Vistagen (Nasdaq: VTGN), a late clinical-stage ...

Social anxiety disorder (SAD) treatment is important for minimizing the condition's impact on your life. People with this anxiety disorder experience intense discomfort in social situations. They're ...

All planned clinical studies in fasedienol U.S. registration-directed Phase 3 program for the acute treatment of social anxiety disorder are underway SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...

its investigational neuroactive pherine nasal spray in Phase 3 development for the acute treatment of social anxiety disorder (SAD).

A new study published in the Journal of Psychiatric Research has found that a self-guided virtual reality app could ...

Vistagen (VTGN) announced enrollment of the first subject in a repeat dose study of fasedienol, its investigational neuroactive pherine nasal ...

fasedienol (PH-94B) is under development for the treatment of social anxiety disorders (social phobia), postpartum anxiety, pre-procedural anxiety (pre-MRI) and adjustment disorder with anxiety ...

Deuterated etifoxine is under development for the treatment of neuropathic and inflammatory pain, multiple sclerosis, epilepsy, generalized anxiety disorder, social anxiety disorder (SAD), post partum ...

It’s hard to know how long anxiety disorders will last when you’re in the thick of them. It was during the mid-2000s that my ...

Pristiq (desvenlafaxine) and Effexor (venlafaxine) are SNRIs. Pristiq treats depression, while Effexor treats depression and ...